The G1021A substitution in the RYR1 gene does not cosegregate with malignant hyperthermia susceptibility in a British pedigree

American Journal of Human Genetics

Volumn 60, Issue 4, 1997, Pages 833-841

  Adeokun, A M ^a   West, S P ^b   Ellis, F R ^c   Halsall, P J ^c   Hopkins, P M ^c   Foroughmand, A M ^d   Iles, D E ^d,e   Robinson, R L ^d   Stewart, A D ^d   Curran, J L ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RYANODINE RECEPTOR;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BODY TEMPERATURE; CALCIUM TRANSPORT; CHILD; DISEASE PREDISPOSITION; DNA DETERMINATION; FEMALE; HUMAN; HYPERMETABOLISM; MAJOR CLINICAL STUDY; MALE; MALIGNANT HYPERTENSION; MUSCLE METABOLISM; PEDIGREE; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE;

CALCIUM CHANNELS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; LOD SCORE; MALE; MALIGNANT HYPERTHERMIA; MEIOSIS; MICROSATELLITE REPEATS; MUSCLE PROTEINS; PEDIGREE; POINT MUTATION; POLYMERASE CHAIN REACTION; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SEQUENCE ANALYSIS, DNA;

EID: 16944363674     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Ball SP, Dorkins HR, Ellis FR, Hall JL, Halsall PJ, Hopkins PM, Muller RF, et al (1993) Genetic linkage analysis of chromosome 19 markers in malignant hyperthermia. Br J Anaesth 70:70-75
2. Ball SP, Johnson KJ (1993) The genetics of malignant hyperthermia. J Med Genet 30:89-93
3. Couch FJ, Hogan K, McCarthy TV, Gregg RG (1991) Dinucleotide repeat polymorphism at the RYR1 locus (19q13.1). Nucleic Acids Res 19:5094
4. Deinard AS, Ruano G, Kidd KK (1992) A dinucleotide repeat polymorphism at the HOX2B locus. Nucleic Acids Res 20: 1171
5. Deufel T, Sudbrak R, Feist Y, Rübsam B, Du Chesne I, Schäfer K-L, Roewer N, et al (1995) Discordance, in a malignant hyperthermia pedigree, between in vitro contracture-test phenotypes and haplotypes for the MHS1 region on chromosome 19q12-q13.2, comprising the C1840T transition in the RYR1 gene. Am J Hum Genet 56:1334-1342.
6. Dietrich W, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N, et al (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75:631-639
7. Ellis FR, Keaney NP, Harriman DGF, Sumner DW, Kyei-Mensah K, Tyrell JH, Hargraves JB, et al (1972) Screening for malignant hyperthermia. BMJ 3:559-561
8. European Malignant Hyperthermia Group (EMHG) (1984) A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. Br J Anaesth 56:1267-1269
9. _ (1985) Laboratory diagnosis of malignant hyperthermia susceptibility (MHS). Br J Anaesth 57:1038
10. Gillard EF, Ostu K, Fujii J, Duff C, de Leon S, Khanna VK, Britt BA, et al (1992) Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia. Genomics 13:1247-1254
11. Hall-Curran JL, Stewart AD, Ball SP, Halsall JP, Hopkins PM, Ellis FR (1993) No C1840 to Tin RYR1 in malignant hyperthermia. Hum Mutat 2:330
12. Harbitz I, Chowghary B, Thomsen PD, Davies W, Kaufmann U, Kran S, Gustavsson I, et al (1990) Assignment of the porcine calcium release channel gene, a candidate for the malignant hyperthermia locus, to the 6p11-q21 segment of chromosome 6. Genomics 8:243-248
13. Hopkins PM, Ellis FR (1995) Inherited disease affecting anaesthesia. In: Healy TEL, Cohen PJ (eds) A Practice of anaesthesia, 6th ed. Edward Arnold, London, pp 938-952
14. Hopkins PM, Halsall PJ, Ellis FR, Stewart AD. Predictive probability for in vitro contracture tests in estimating likelihood of malignant hyperthermia susceptibility. Anesth Analg (in press)
15. Iaizzo PA, Lehmann-Horn F (1995) Anesthetic complications in muscle disorders. Anesthesiology 82:1093-1096
16. 2/δ-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families. Hum Mol Genet 3:969-975
17. Iles DE, Segers B, de Jong P, Alleman J, Wieringa B (1992) Dinucleotide repeat polymorphism at the D19S191 locus. Nucleic Acids Res 20:1170
18. 1-and γ-subunits of the human skeletal muscle L-type voltage-dependent calcium channel on chromosome 17q and exclusion as candidate genes for malignant hyperthermia susceptibility. Hum Mol Genet 2:863-868
19. Kajiwara K, Berson EL, Dryja TP (1994) Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science 264:1604-1608
20. Kalow W, Britt BA, Terreau ME, Haist C (1970) Metabolic error of muscle metabolism after recovery from malignant hyperthermia. Lancet 2:895-898
21. Kausch K, Lehmann-Horn F, Janka M, Wieringa B, Grimm T, Müller CR (1991) Evidence for linkage of the central core disease locus to the proximal long arm of human chromosome 19. Genomics 10:765-769
22. Kunkel LM, Smith KD, Boyer SH, Borgaonker DS, Wachtel SS, Miller OJ, Berg WR, et al (1977) Analysis of human Y chromosome specific reiterated DNA in chromosome variants. Proc Natl Acad Scii USA 74:1245-1249
23. Levitt RC, Olckers A, Meyers S, Fletcher JE, Rosenberg H, Isaacs H, Meyers DA (1992) Evidence for the localization of a malignant hyperthermia susceptibility locus (MSH2) to chromosome 17q. Genomics 14:562-566
24. MacLennan DH, Duff C, Zorzato F, Fujii J, Phillips M, Korneluk RG, Frodis W, et al (1990) Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature 343:559-561
25. McCarthy TV, Healy JMS, Heffron JJA, Lehane M, Deufel T, Lehmann-Horn F, Farrall M, et al (1990) Localisation of the malignant hyperthermia susceptibility locus to human chromosome 19q12-q13.2. Nature 343:562-564
26. McClatchey AI, Trofatter J, McKenna-Yasek D, Raskind W, Bird T, Pericak-Vance M, Gilchrist J, et al (1992) Dinucleotide repeat polymorphisms at the SCN4A locus suggest allelic heterogeneity of hyperkalemic periodic paralysis and paramyotonia congenita. Am J Hum Genet 50:896-901
27. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
28. Mulley JC, Kozman HM, Phillips HA, Gedeon AK, McCure JA, Iles DE, Gregg RG, et al (1993) Refined genetic localization for central core disease. AmJ Hum Genet 52:398-405
29. NIH/CEPH Collaborative Mapping Group (1992) A comprehensive genetic linkage map of the human genome. Science 258:67-86
30. 1 subunit as frequent causes of malignant hyperthermia. J Med Genet 32:913-914
31. Oppenheim A, Yaaru A, Rund D, Rachmilewitz EA, Nathan D, Wong C, Kazazian HH Jr, et al (1990) Intrinsic potential for high fetal hemoglobin production in a Druze family with β-thalassemia is due to an unlinked genetic determinant. Hum Genet 86:175-180
32. Plassart E, Reboul J, Rime C-S, Recan D, Millasseau P, Eymard B, Pelletier J, et al (1994) Mutations in the muscle sodium channel gene (SCN4A) in 13 French families with hyperkalaemic periodic paralysis and paramyotonia congenita: phenotype to genotype correlations and demonstration of the predominance of two mutations. Eur J Hum Genet 2: 110-124
33. Polymeropoulos MH, Rath DS, Xiao H, Merril CR (1991) A simple sequence repeat polymorphism at the growth hormone locus. Nucleic Acids Res 19:689
34. Quane KA, Keating KE, Manning BM, Healy JMS, Monsieurs K, Heffron JJA, Lehane M, et al (1994) Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies. Hum Mol Genet 3:471-476
35. Serfas KD, Bose D, Patel L, Wrogemann K, Phillips MS, MacLennan DH, Greenberg CR (1996) Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family. Anesthesiology 84:322-329
36. Sudbrak R, Procaccio V, Klausnitzer M, Curran JL, Monsieurs K, Van Broeckhoven C, Ellis R, et al (1995) Mapping of a further malignant hyperthermia susceptibility locus to chromosome 3q13.1. Am J Hum Genet 56:684-691
37. 1306-to-alanine mutation in the adult muscle sodium channel α-subunit gene. Anesthesiology 82:1097-1103
38. Weber JL, May PE (1989) Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 44:388-396
39. Weber JL, May PE, Kappel C (1990) Dinucleotide repeat polymorphism at the D19S49 locus. Nucleic Acids Res 18:1927
40. Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G, et al (1992) A second generation linkage map of the human genome. Nature 359:794-801
41. West SP (1996) The genetics of malignant hyperthermia. In: Ellis FR, Hopkins PM (eds) Hyperthermic and hypermetabolic disorders. Cambridge University Press, Cambridge, pp 184-201